General Information of the Compound
| Compound ID |
CP0775911
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N1-(3,5-dimethoxyphenyl)-N1-(3-(1-isopropyl-1H-pyrazol-4-yl)quinoxalin-6-yl)-N2-methylethane-1,2-diamine hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H31ClN6O2
|
||||||||||||||||||
| Molecular Weight |
483.016
|
||||||||||||||||||
| Canonical SMILES |
CNCCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C(C)C)c3)nc2c1.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H30N6O2.ClH/c1-17(2)31-16-18(14-28-31)25-15-27-23-7-6-19(12-24(23)29-25)30(9-8-26-3)20-10-21(32-4)13-22(11-20)33-5;/h6-7,10-17,26H,8-9H2,1-5H3;1H
Show/Hide
|
||||||||||||||||||
| InChIKey |
JDECXTQTKUXRLD-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01411, Fibroblast growth factor receptor 3
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT00864, Vascular endothelial growth factor receptor 2